• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Open Forum Infect Dis . Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in Decedents Undergoing Forensic Postmortem Examinat

tetano

Editor, Senior Moderator
Open Forum Infect Dis


. 2022 Apr 10;9(5):ofac142.
doi: 10.1093/ofid/ofac142. eCollection 2022 May.
Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in Decedents Undergoing Forensic Postmortem Examination: Feasibility for Real-Time Pandemic Surveillance


Sally B Coburn[SUP] 1 [/SUP], Yukari C Manabe[SUP] 2 [/SUP], Oliver Laeyendecker[SUP] 2 3 [/SUP], Susan G Sherman[SUP] 4 [/SUP], Owen R Baker[SUP] 2 [/SUP], Thomas C Quinn[SUP] 2 3 [/SUP], Lindsey A Graham[SUP] 5 [/SUP], F Dennis Thomas[SUP] 5 [/SUP], Pamela Southall[SUP] 6 [/SUP], Victor W Weedn[SUP] 7 [/SUP], Johnathon Ehsani[SUP] 8 [/SUP], Ethan Klock[SUP] 2 [/SUP], Rong Li[SUP] 6 [/SUP], Wendy C Shields[SUP] 8 [/SUP], Jeffrey Paul Michael[SUP] 8 [/SUP], Ling Li[SUP] 6 9 [/SUP], Keri N Althoff[SUP] 1 [/SUP]



Affiliations

Abstract

Background: Population-based seroprevalence studies offer comprehensive characterization of coronavirus disease 2019 (COVID-19) spread, but barriers exist and marginalized populations may not be captured. We assessed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody seroprevalence among decedents in Maryland over 6 months in 2020.
Methods: Data were collected on decedents undergoing forensic postmortem examination in Maryland from 24 May through 30 November 2020 from whom a blood specimen could be collected. Those with available blood specimens were tested with the CoronaCHEK lateral flow antibody assay. We assessed monthly seroprevalence compared to the statewide estimated number of cases and proportion of positive test results (testing positivity). We used Poisson regression with robust variance to estimate adjusted prevalence ratios (aPRs) with 95% confidence intervals (CIs) for associations of demographic characteristics, homelessness, and manner of death with SARS-CoV-2 antibodies.
Results: Among 1906 decedents, 305 (16%) were positive for SARS-CoV-2 antibodies. Monthly seroprevalence increased from 11% to 22% over time and was consistently higher than state-level estimates of testing positivity. Hispanic ethnicity was associated with 2- to 3.2-fold higher seropositivity (P < .05) irrespective of sex. Deaths due to motor vehicle crash were associated with 62% increased seropositivity (aPR, 1.62 [95% CI, 1.15-2.28]) vs natural manner of death. Though seroprevalence was lower in decedents of illicit drug overdose vs nonoverdose in early months, this shifted, and seroprevalence was comparable by November 2020.
Conclusions: Decedents undergoing forensic postmortem examination, especially those dying due to motor vehicle trauma, may be a sentinel population for COVID-19 spread in the general population and merits exploration in other states/regions.

Keywords: SARS-CoV-2 antibodies; decedents; drug overdose; motor vehicle crash; seroprevalence.
 
Back
Top Bottom